All bills
H.R. 10223·119th Congress·House Bill

End Tuberculosis Now Act of 2026

Stage not suppliedTrack

The source supplies the latest action, but no lifecycle stage.

Latest action (2 Sep 2026): Referred to the House Committee on Foreign Affairs.

What this bill does

H.R. 10223, the End Tuberculosis Now Act of 2026, would rewrite the existing tuberculosis (TB) assistance provision in the Foreign Assistance Act of 1961 to update U.S. policy on combating TB globally. It authorizes the President to provide foreign assistance for TB prevention, diagnosis, treatment, and research, with priority given to strengthening health systems, expanding access to diagnostics and treatment (including for drug-resistant TB), supporting vaccine and drug research, and integrating TB programs into broader pandemic-preparedness and primary health care efforts. The bill sets specific goals for 2027–2030, including reducing TB incidence and mortality rates, achieving 90% diagnosis and treatment rates, and providing preventive treatment to 30 million people. It also requires annual reports to Congress on program activities and TB research, plus a Government Accountability Office evaluation after four years. The provision would expire on January 1, 2033.

The bill primarily affects U.S. foreign assistance agencies, partner countries with high TB rates, international health organizations, and populations affected by TB worldwide, including those with drug-resistant forms of the disease. It does not create new domestic programs but directs how existing foreign aid authority is used and reported on.

The bill was introduced in the House on September 2, 2026, and referred to the Committee on Foreign Affairs. It would need committee consideration, House and Senate passage, and the President’s signature to become law.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 2 Sep 2026

    Referred to the House Committee on Foreign Affairs.

Common questions

What does H.R. 10223 do?
H.R. 10223, the End Tuberculosis Now Act of 2026, would rewrite the existing tuberculosis (TB) assistance provision in the Foreign Assistance Act of 1961 to update U.S. policy on combating TB globally. It authorizes the President to provide foreign assistance for TB prevention, diagnosis, treatment, and research, with priority given to strengthening health systems, expanding access to diagnostics and treatment (including for drug-resistant TB), supporting vaccine and drug research, and integrating TB programs into broader pandemic-preparedness and primary health care efforts. The bill sets specific goals for 2027–2030, including reducing TB incidence and mortality rates, achieving 90% diagnosis and treatment rates, and providing preventive treatment to 30 million people. It also requires annual reports to Congress on program activities and TB research, plus a Government Accountability Office evaluation after four years. The provision would expire on January 1, 2033. The bill primarily affects U.S. foreign assistance agencies, partner countries with high TB rates, international health organizations, and populations affected by TB worldwide, including those with drug-resistant forms of the disease. It does not create new domestic programs but directs how existing foreign aid authority is used and reported on. The bill was introduced in the House on September 2, 2026, and referred to the Committee on Foreign Affairs. It would need committee consideration, House and Senate passage, and the President’s signature to become law.
Has H.R. 10223 become law?
The source does not supply a confirmed lifecycle stage for H.R. 10223. Check the latest action and official source below.
Who sponsored H.R. 10223?
H.R. 10223 was sponsored by Rep. Bera, Ami [D-CA-6] (D-CA), with 22 cosponsors.
What's the latest action on H.R. 10223?
Referred to the House Committee on Foreign Affairs. (2 Sep 2026).

Related bills in International Affairs

More bills from Rep. Bera, Ami [D-CA-6]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.